Field Epidemiology · Diagnostic Strategy Lab

Malaria Diagnostics &
Screening Strategy

Bayesian performance, test operating characteristics, and the cost of missed cases
Tests in Use
● RDT (HRP2/pLDH)
● Microscopy (thick film)
● PCR (nested/qPCR)
Pop. = 10,000 persons
1,000 simulated screens
⚕ The same test sensitivity and specificity produce very different predictive values depending on background prevalence. Adjust prevalence, test characteristics, and screening strategy to observe how the surveillance pyramid changes — and how missed sub-patent infections sustain transmission.
Diagnostic Test
Test Characteristics
Sensitivity (Se) P(T+ | Disease+) 92%
Specificity (Sp) P(T− | Disease−) 97%
Sub-patent detection Sensitivity for low-density infections 10%
Epidemiological Setting
True prevalence Including sub-patent infections 10%
Sub-patent fraction Of all true infections 30%
Screening Strategy
Population coverage Fraction screened/treated 80%
Cost per treatment (ACT) USD $2.5
Operating Metrics
PPV
—
pos. pred. value
NPV
—
neg. pred. value
Missed cases
—
per 10,000
False treats
—
per 10,000
NNS
—
need to screen
Total cost
—
per 10,000 pop.
Programme Cost Breakdown
Testing—
True-positive treatment—
False-positive treatment—
Total—
Confusion Matrix
Fig. I · N = 10,000
Test Positive
Test Negative
Disease +
Disease −
True Positive
—
Detected & treated
False Negative
—
Missed — reservoir
False Positive
—
Unnecessary Rx
True Negative
—
Correctly cleared
Adjust prevalence and test characteristics to observe how the cell counts shift.
PPV & NPV across Prevalence
Fig. II · Bayesian sweep
The vertical line marks the current prevalence. PPV collapses at low prevalence even with high sensitivity — the core Bayesian insight.
Test Comparison — ROC
Fig. III
Each test's operating point on the ROC plane. PCR dominates; microscopy and RDT trade sensitivity for cost.
Missed Cases vs Prevalence
Fig. IV
Missed infections per 10,000 screened. Sub-patent reservoir is invisible to RDT and microscopy.
Surveillance Pyramid & Transmission Reservoir
Fig. V
Stacked bar showing the fate of all true infections under the current screening strategy. Missed sub-patent infections sustain onward transmission.
Field Interpretation
Adjust parameters to generate interpretation.

Bayesian Diagnostic Equations

PPV = Se·P / [Se·P + (1−Sp)·(1−P)]
NPV = Sp·(1−P) / [Sp·(1−P) + (1−Se)·P]
TP = N·P·[Se_patent·(1−f_sub) + Se_sub·f_sub]
FN = N·P − TP    LR+ = Se/(1−Sp)
P=prevalence · f_sub=sub-patent fraction · Se_sub=sub-patent sensitivity